NeoVax With Nivolumab Feasible in Platinum-Sensitive Ovarian Cancer Study
A phase 1 study finds NeoVax, a personalised neoantigen vaccine, feasible with nivolumab in platinum-sensitive ovarian cancer, with acceptable safety.
Read more
Continuous Glucose Monitors Help Type 2 Diabetes Patients Stay in Range Longer
A landmark trial finds continuous glucose monitors help adults with type 2 diabetes who do not use insulin spend about five more hours a day in target range.
Read more